TNFSF13B and infection: Of note pre-treating RABV-ED51-BAFF with the anti-BAFF neutralizing antibody did not influence the ability for the virus to infect BSR cells (Fig 4C), indicating that the antibody is not hindering B cell infection and activation via steric hinderance.